أعرض في EDS

555 Clinical and pharmacodynamic biomarker results from PORTER, a multi-cohort phase 1 platform trial of combination immunotherapy for metastatic castration-resistant prostate cancer patients

التفاصيل البيبلوغرافية
العنوان: 555 Clinical and pharmacodynamic biomarker results from PORTER, a multi-cohort phase 1 platform trial of combination immunotherapy for metastatic castration-resistant prostate cancer patients
المؤلفون: Matthew Galsky, Karen Autio, Kristopher Wentzel, Julie Graff, Terence Friedlander, Julie Densmore, Christopher Cabanski, Kristin Shotts, Tim Howes, Jia Yu, Elaine Eisenbeisz, Marko Spasic, Stephen Maddock, Diane DaSilva, Dinesh Kumar, Jonni Moore, Richard Schretzenmair, Jennifer Lata, Arron Xu, Emma Reuschel, Snehal Wani, Matthew Morrow, Jeffrey Skolnik, Sandra Santulli-Marotto, Lacey Padron, Lisa Butterfield, Theresa LaVallee, Samantha Bucktrout, Michael Yellin, Tibor Keler, Lisa Salvador, Jill O'Donnell-Tormey, Vanessa Lucey, Justin Fairchild, Ute Dugan, Nina Bhardwaj, Sumit Subudhi, Lawrence Fong
المصدر: Regular and Young Investigator Award Abstracts.
بيانات النشر: BMJ Publishing Group Ltd, 2022.
سنة النشر: 2022
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e2ca65175f978ff706b50c9dae348464
https://doi.org/10.1136/jitc-2022-sitc2022.0555
رقم الأكسشن: edsair.doi...........e2ca65175f978ff706b50c9dae348464
قاعدة البيانات: OpenAIRE
الوصف
الوصف غير متاح.